Vivo Capital, LLC Bolt Biotherapeutics, Inc. Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding BOLT
# of Institutions
4Shares Held
685KCall Options Held
0Put Options Held
0-
Hawkeye Capital Management, LLC Miami Beach, FL415KShares$2.28 Million1.06% of portfolio
-
Black Rock Inc. New York, NY267KShares$1.47 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ2.36KShares$12,9520.0% of portfolio
-
Jpmorgan Chase & CO New York, NY906Shares$4,9830.0% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $207M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...